Tech Center 1600 • Art Units: 1621
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18552878 | COMBINED USE OF MULTIKINASE INHIBITOR | Non-Final OA | TRANSTHERA SCIENCES (NANJING), INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy